Individualised Weaning From Mechanical Ventilation in General ICU

Ventilatory Failure Clinical Trial

— iCareWean_CW  

Official title:

Weaning From Mechanical Ventilation: Comparison of Open‐Loop Decision Support System and Routine Care, in the General Intensive Care Unit

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03249623
• Other study ID #: 226610
• Secondary ID: 2017-002627-25
• Status: Recruiting
• Phase: N/A
• Start date: December 11, 2017
• Est. completion date: July 30, 2021

Study information

• Verified date: July 2020
• Source: Chelsea and Westminster NHS Foundation Trust
• Contact: Damon P Foster
• Phone: +44 2033156887
• Email: essam.ramhamadany[@]chelwest.nhs.uk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Patients residing in the intensive care unit typically receive mechanical ventilatory support. Selecting the appropriate level of mechanical ventilation is not trivial, and it has been shown that lung protective settings can reduce mortality in patients with lung injury. Despite being a life- saving therapy, duration of mechanical ventilation should be kept at a minimum to reduce effects of immobilization, long-term sedation, patient discomfort, risk of ventilator associated pneumonia, leading to decreasing mortality and economic costs etc. The duration of mechanical ventilation is also an important factor in weaning from ventilatory support, with prolonged ventilator support making the weaning process more difficult.

The purpose of this study is to compare mechanical ventilation following advice from the Beacon Caresystem to that of standard care in general medical intensive care unit (ICU) patients, from the start of requiring invasive mechanical ventilation until successful extubation. The Beacon Caresystem will be compared to standard care to investigate whether use of the system results in similar care or reduced time for weaning from mechanical ventilation.

Description:

All patients admitted to the ICU with mechanical ventilation are screened for inclusion. Patients receiving invasive mechanical ventilation (≥ 24 h) will be considered for inclusion in the study on a daily basis. Patient screening will be performed by clinical researchers or a delegated clinician and consent/assent will be sought. Then patients will be randomised to the Beacon group or Standard Care group. Randomisation will be performed using sealed envelopes, and in blocks of patients, allowing interim analysis of results in appropriate steps during the study. To avoid that results are affected by patient disease type, randomisation will be stratified for equal distribution between randomisation groups.

Patients will be randomly assigned to either standard care of mechanical ventilation, or to follow the advice of the Beacon Caresystem. The results of these two strategies will then be compared based upon the following outcome measurements.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 274
• Est. completion date: July 30, 2021
• Est. primary completion date: November 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient is expected to be on invasive mechanical ventilation more 24 hours.

• Age > 18 years

• Haemodynamically stable (with instability defined by the presence of two or more of the following criteria: acidosis pH < 7.2, poor urine output < 0.5ml/kg, use of vasopressors, e.g. noradrenline > 25 µg/min).

• Patient consent or, in the case that the patient is unable, assent from the next of kin or treating physician following understanding and accept of oral and written information describing the study

Exclusion Criteria:

• The absence of an arterial catheter for blood sampling at study start.

• Medical history of home mechanical ventilation which may lead to prolonged stay in the ICU, including long term oxygen therapy and non-invasive ventilation not associated with sleep apnoa.

• Clinical conditions requiring treatment with extracorporeal membrane oxygenation, i.e. an inspired oxygen of 100% for more than 24 hours.

• Head trauma or other conditions where intra-cranial pressure may be elevated and tight regulation of arterial CO2 level is paramount.

• Primary neurological patients (Glasgow coma score <10, neurologic damage with limited prognosis, stroke hemiplegia).

• Severe heart failure, classified as grade 4 of the Association of Cardiology guidelines [2].

• End stage liver disease.

• Multiple medical ICU admissions, i.e. more than one admission.

• Corrective orthognathic surgery.

• Esophageal surgery.

• Morbidly obese patients defined as either BMI>45, or 35<BMI<45 with APACHEII score on admission greater than 24.

• Pregnancy.

• Mechanical ventilation initiated for more for 24 hours in other centers

Related Conditions & MeSH terms

• Hypoventilation
• Ventilatory Failure

Intervention

Device:
• Beacon Caresystem
The core of the system is a set of physiological models including pulmonary gas exchange, acid-base chemistry, lung mechanics, and respiratory drive. The Beacon Caresystem tunes these models to the individual patient such that they describe accurately current measurements. Once tuned, the models are used by the system to simulate the effects of changing ventilator settings. The results of these simulations are then used calculate the clinical benefit of changing ventilator settings by balancing the competing goals of mechanical ventilation.

Locations

Country	Name	City	State
United Kingdom	The Magill Department of Anaesthesia, Chelsea and Westminster Hospital	London

Sponsors (2)

Lead Sponsor	Collaborator
Chelsea and Westminster NHS Foundation Trust	Aalborg University

Country where clinical trial is conducted

United Kingdom, 

References & Publications (3)

Rees SE, Karbing DS. Determining the appropriate model complexity for patient-specific advice on mechanical ventilation. Biomed Tech (Berl). 2017 Apr 1;62(2):183-198. doi: 10.1515/bmt-2016-0061. — View Citation

Rees SE, Karbing DS. Model-based advice for mechanical ventilation: From research (INVENT) to product (Beacon Caresystem). Conf Proc IEEE Eng Med Biol Soc. 2015;2015:5331-4. doi: 10.1109/EMBC.2015.7319595. — View Citation

Weinreich UM, Thomsen LP, Rees SE, Rasmussen BS. The effects of oxygen induced pulmonary vasoconstriction on bedside measurement of pulmonary gas exchange. J Clin Monit Comput. 2016 Apr;30(2):207-14. doi: 10.1007/s10877-015-9703-x. Epub 2015 May 12. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Length of mechanical ventilation	Length of mechanical ventilation, defined as either the time of intubation in the ICU, or the time of admission to the ICU following previous intubation for surgery, and until successful extubation, with successful	Daily assessment of requirement of mechanical ventilation from the time of randomisation until the date of liberation from mechanical ventilation, up to 12 months.
Secondary	Time to spontaneous ventilation	It is defined as the time taken to wean from mandatory mode of ventilation	Daily assessment of spontaneous ventilation from the date of randomisation until the date the patient starts breathing spontaneously, up to 12 months.
Secondary	Time to extubation	It is defined as the time the decision is made to proceed with removal of the endotracheal tube or tracheal decannulation.	Daily assessment of time to extubation from the date of initiation of spontaneous ventilation until the date of liberation from mechanical ventilation, up to 12 months.

External Links

•   Details of the Beacon System
•   Sponsor website